Biomea Fusion, Inc. Stock-Based Compensation
Biomea Fusion, Inc. (BMEA) reported Stock-Based Compensation of $3.17 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-05
- Biomea Fusion, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $1.59M, a 38.32% decline year-over-year.
- Biomea Fusion, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $1.58M, a 50.08% decline year-over-year.
- Biomea Fusion, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.84M, a 59.06% decline year-over-year.
- Biomea Fusion, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $1.94M, a 59.09% decline year-over-year.
- Biomea Fusion, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $9.52M, a 50.14% decline from fiscal 2024.
- Biomea Fusion, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $19.09M, a 35.12% increase from fiscal 2023.
- Biomea Fusion, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $14.13M, a 36.72% increase from fiscal 2022.
- Biomea Fusion, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $10.34M, a 65.80% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $3.17M 10-Q · filed 2026-08-05 | $5.01M derived: sum of 3 quarters · filed 2026-08-05 | $6.95M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.58M 10-Q · filed 2026-05-11 | $3.42M derived: sum of 2 quarters · filed 2026-05-11 | $5.36M derived: sum of 3 quarters · filed 2026-05-11 | $7.93M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $3.78M derived: sum of 2 quarters · filed 2026-03-24 | $6.35M derived: sum of 3 quarters · filed 2026-08-05 | $9.52M 10-K · filed 2026-03-24 |
| 2025-09-30 | $1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $4.51M derived: sum of 2 quarters · filed 2026-08-05 | $7.68M 10-Q · filed 2025-11-04 | $12.17M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $2.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $5.74M 10-Q · filed 2026-08-05 | $10.23M derived: sum of 3 quarters · filed 2026-08-05 | $14.97M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $3.17M 10-Q · filed 2026-05-11 | $7.66M derived: sum of 2 quarters · filed 2026-05-11 | $12.40M derived: sum of 3 quarters · filed 2026-05-11 | $17.24M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $4.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $9.23M derived: sum of 2 quarters · filed 2026-03-24 | $14.07M derived: sum of 3 quarters · filed 2026-03-24 | $19.09M 10-K · filed 2026-03-24 |
| 2024-09-30 | $4.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $9.58M derived: sum of 2 quarters · filed 2025-11-04 | $14.60M 10-Q · filed 2025-11-04 | $18.47M derived: sum of 4 quarters · filed 2026-03-24 |
| 2024-06-30 | $4.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $9.86M 10-Q · filed 2025-08-05 | $13.73M derived: sum of 3 quarters · filed 2026-03-24 | $17.32M derived: sum of 4 quarters · filed 2026-03-24 |
| 2024-03-31 | $5.02M 10-Q · filed 2025-05-05 | $8.89M derived: sum of 2 quarters · filed 2026-03-24 | $12.48M derived: sum of 3 quarters · filed 2026-03-24 | $15.92M derived: sum of 4 quarters · filed 2026-03-24 |
| 2023-12-31 | $3.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $7.46M derived: sum of 2 quarters · filed 2026-03-24 | $10.90M derived: sum of 3 quarters · filed 2026-03-24 | $14.13M 10-K · filed 2026-03-24 |
| 2023-09-30 | $3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $7.03M derived: sum of 2 quarters · filed 2024-10-29 | $10.27M 10-Q · filed 2024-10-29 | $12.98M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-06-30 | $3.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $6.67M 10-Q · filed 2024-07-31 | $9.38M derived: sum of 3 quarters · filed 2025-03-31 | $12.12M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-03-31 | $3.23M 10-Q · filed 2024-05-02 | $5.95M derived: sum of 2 quarters · filed 2025-03-31 | $8.68M derived: sum of 3 quarters · filed 2025-03-31 | $11.24M derived: sum of 4 quarters · filed 2025-03-31 |
| 2022-12-31 | $2.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $5.45M derived: sum of 2 quarters · filed 2025-03-31 | $8.01M derived: sum of 3 quarters · filed 2025-03-31 | $10.34M 10-K · filed 2025-03-31 |
| 2022-09-30 | $2.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30 | $5.29M derived: sum of 2 quarters · filed 2023-10-30 | $7.62M 10-Q · filed 2023-10-30 | $9.55M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-06-30 | $2.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-31 | $4.89M 10-Q · filed 2023-07-31 | $6.82M derived: sum of 3 quarters · filed 2024-03-28 | $8.74M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-03-31 | $2.33M 10-Q · filed 2023-05-02 | $4.26M derived: sum of 2 quarters · filed 2024-03-28 | $6.18M derived: sum of 3 quarters · filed 2024-03-28 | $7.64M derived: sum of 4 quarters · filed 2024-03-28 |
| 2021-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $3.85M derived: sum of 2 quarters · filed 2024-03-28 | $5.32M derived: sum of 3 quarters · filed 2024-03-28 | $6.23M 10-K · filed 2024-03-28 |
| 2021-09-30 | $1.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $3.38M derived: sum of 2 quarters · filed 2022-11-07 | $4.30M 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | $2.38M 10-Q · filed 2022-08-01 | ||
| 2021-03-31 | $919.00K 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $322.00K 10-K · filed 2023-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |